SteriLumen is patent protected technology that utilizes ultraviolet light for killing pathogens on surfaces in an easy and affordable manner.
SteriLumen has developed and patented ultraviolet light devices and technology to address the issue of health care acquired infections including the coronavirus pandemic. HAI’s kill ninety-nine thousand people per year in hospital settings and the coronavirus impacts are felt beyond the healthcare industry, touching every market and industry. SteriLumen technology kills the OC43 human coronavirus pathogen as well as other common HAIs such as C-Diff, MRSA, and E.coli. Safe, effective, and laboratory validated, SteriLumen technology is a patented revolution with limitless real-world applications.
Pathogen destroying technology addresses a $40B healthcare problem and a $110B hospitality problem arising from the rampant spread of virulent pathogens such as the coronavirus.
SteriLumen is the first and only patented touchless and fully automated UVC infection prevention system. Destroys coronavirus - 100% laboratory tested
Utilize the SteriLumen infection prevention technology with our Disinfecting Drain Device. Disinfecting the hard to reach drain interior. Entirely waterproof.
Retrofit any existing lighted mirror to include the SteriLumen signature infection prevention technology. Easy installation in under 45 minutes.
SLA-1 Cloud Service
Track and analyze your SteriLumen device's ultraviolet output and timing. Come with every SteriLumen product.
SteriLumen UVC Technology Tested Against Human Coronavirus OC43
Third party independent laboratory testing of SteriLumen
Our laboratory tested both the mirror and drain units against H1N1 human influenza A virus. The units demonstrated a greater than 2.91-log (mirror) and a 4.21-log (drain) kill after 2 hours and 15 minutes respectively.
Over the course of 2 hours, it is estimated that the mirror unit has a fluency of approximately 300mJ/cm2.
The drain unit has an estimated fluency of 36mJ/cm2 after a 15 minute exposure.
For entire lab report, please see the Resources Page.
Stay in touch
Benefits of subscribing to our newsletter here.